The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.
about
Difference in clinical course, genetics, and the microbiome between familial and sporadic inflammatory bowel diseases.Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator? Author's reply.Editorial: co-existing immune-mediated disease in inflammatory bowel diseases - a new disease severity indicator?
P2860
The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
The impact of co-existing immu ...... n inflammatory bowel diseases.
@en
The impact of co-existing immu ...... n inflammatory bowel diseases.
@nl
type
label
The impact of co-existing immu ...... n inflammatory bowel diseases.
@en
The impact of co-existing immu ...... n inflammatory bowel diseases.
@nl
prefLabel
The impact of co-existing immu ...... n inflammatory bowel diseases.
@en
The impact of co-existing immu ...... n inflammatory bowel diseases.
@nl
P2093
P2860
P356
P1476
The impact of co-existing immu ...... in inflammatory bowel diseases
@en
P2093
P2860
P304
P356
10.1111/APT.13940
P407
P577
2017-01-20T00:00:00Z